???? Claim: “No Big Pharma (BP) has done a deal with an
???? Claim: “No Big Pharma (BP) has done a deal with an OTC biotech drug in the last decade.”
False or highly misleading.
• OTC (Over-the-Counter) typically refers to how a stock trades, not the legitimacy of a biotech’s drug pipeline. Many OTC-traded biotechs have had partnerships or acquisitions by larger pharmaceutical companies, especially in the early stages of development or for access to innovative science.
• Examples:
• GW Pharmaceuticals (initially traded OTC in the U.S.) was acquired by Jazz Pharmaceuticals in 2021 for $7.2 billion.
• Smaller firms with pink sheet/OTC origins have been acquired or partnered if the science and clinical data are promising.
⸻
???? Claim: “CYDY also has the ‘fraud taint’ from the conviction of their CEO.”
Partly true but lacks context.
• Former CEO Nader Pourhassan was charged and convicted for misleading investors regarding Leronlimab’s efficacy, especially during the COVID pandemic.
• However, this does not permanently disqualify a biotech from future partnerships, especially if:
• New, credible management is in place.
• The science shows potential.
• The company resolves compliance issues with the SEC or FDA.
???? Claim: “Progenics attempted to sell LL for years and no BP would touch it so they shelved it.”
False.
• Progenics never owned Leronlimab. Leronlimab (also known as PRO 140) was originally developed by Progenics, but they licensed it to CytoDyn in 2012. Afterward, Progenics had no control over its development or marketing.
• It was not a matter of Progenics “shelving” Leronlimab—they divested it. Their focus shifted elsewhere, especially after merging with Lantheus Holdings in 2020.
⸻
???? Claim: “The patents are owned by Progenics and AbbVie, limiting the cash that would go to CYDY.”
Not entirely accurate.
• The core patents around Leronlimab (PRO 140) were licensed to CytoDyn from Progenics. CytoDyn has rights to develop and commercialize the drug.
• AbbVie is not known to be involved with Leronlimab’s IP portfolio.
• The terms of the license include milestone payments and royalties, which is standard. But CytoDyn retains commercialization rights, and if successful, could still generate substantial revenue.
• CytoDyn has also filed for additional patents around new indications, combinations, and formulations.
12
CytoDyn Inc (CYDY) Stock Research Links
LETS GO!!!
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Fifty-one point six is the number that makes this announcement worth chewing on. TCL CSOT says it has moved ultrahigh-mobility oxide technology into mass production on an 8.6-generation line, clearing the 50 cm² V?¹ s?¹ threshold that has largely belonged to lab-talk and presentation slides. For display people, that is not decorative science. It could change the old...
Continue Reading
A language gap rarely makes the loudest noise in an earnings call, yet it can quietly wreck a sales effort, a hiring plan, or a customer relationship. ACTFL's updated 2026 employer study puts some hard edges around that problem: U.S. businesses say multilingual capability is not a nice cultural accessory. It is increasingly part of operating the business. Demand Has Moved...
Continue Reading
One courtroom result can expose a whole warehouse of institutional neglect, and this one lands with a grim thud. New York has agreed to pay $1.2 million to resolve a claim involving sexual assault by a former corrections officer at Bayview Correctional Facility in Manhattan. The settlement came after a two-week Adult Survivors Act bellwether trial concluded on November 17...
Continue Reading
Two old hands entering a boardroom can matter more than another glossy growth slogan, especially in aircraft maintenance, where a delayed part can ground an airplane and turn a customer relationship sour in a hurry. MTI Aviation has added Tony DiSimone Sr. and Aviv Tzur to its board, a move announced November 20, 2026, after Acorn Capital Management took a majority...
Continue Reading
Desert weather is unforgiving, and apparently the scalp does not get a pass. In a Nov. 20, 2026 discussion, Scottsdale and Tucson hair-restoration physician Dr. Sharon A. Keene frames Arizona hair concerns around something easy to overlook: the condition of the skin beneath the hair. That is a more sensible starting point than treating every strand in the shower like it...
Continue Reading
A pet bowl can become a crisis marker faster than people admit. Housing trouble, empty cupboards, a hurricane, or an unaffordable veterinary bill can turn a loved animal into one more impossible responsibility. That is the uncomfortable reality behind PetSmart Charities' decision to create a vice president of strategic programs and partnerships role and appoint Heather...
Continue Reading
A December podium in Simi Valley has suddenly become a market-relevant appointment. The Ronald Reagan Presidential Foundation and Institute says President Donald J. Trump will deliver the keynote at the 2026 Reagan National Defense Forum on Friday, December 4, at 3:00 p.m. Pacific time, or 6:00 p.m. Eastern. That is the whole hard fact pattern so far. No agenda, no...
Continue Reading
Back-office drudgery rarely gets anyone’s pulse racing, yet it can quietly chew through a small business’s time and cash. That is why Melio’s latest recognition as Software Experts’ top pick for accounts payable automation deserves a look. The product pitch is straightforward: pull bills, approvals, payments and reconciliation into one workflow rather than leaving...
Continue Reading
Three very different piles of money are jamming up the November 20 NYSE slate, and that contrast is the whole point. Private music catalogs, space-and-defense communications, and a new stock-and-bond ETF do not belong in the same bucket. Yet all three are competing for investor attention before the opening bell, alongside Danaos Corporation's 20th listing anniversary....
Continue Reading
A treatment bill can wreck a household long before a diagnosis does. That is the uncomfortable reality behind Hope Charities' new Access to Care website, a centralized resource meant to show people in the bleeding disorders community when diagnosis-specific charitable assistance funds are available. This is not flashy technology, nor should it be treated like some grand...
Continue Reading
Top 5 Most Recently Viewed Articles
Transforming Notary Services In the realm of notary services, efficiency and organization are paramount. An inventive spirit from Richmond has stepped forward, seeking to revolutionize the notary journal—a pivotal tool for professionals in this industry. The concept, aptly named the NOTARY JOURNAL, aims to streamline the process of recording signatures and vital...
Continue Reading
Leadership Reimagined for a Changing World The market's no walk in the park right now, and Cappfinity’s stepping in with its new Leadership Contribution Platform to tackle the very thing that every organization’s biting nails over—leadership. We're talking about a total shift in how leadership’s gauged, understood, and developed. And yep, it’s about time someone...
Continue Reading
Spain Boosts Cybersecurity Innovation with Quantix Investment The Spanish government's latest initiative aims to enhance cybersecurity and microelectronics innovation through an impressive investment of €19.6 million in Quantix. This investment is part of a broader effort to develop a cutting-edge Cybersecurity and Microelectronics Center in a strategic region....
Continue Reading
Innovative Income Strategies with New Simplify ETFs Launch In a move designed to empower investors, Simplify Asset Management has introduced two innovative Exchange Traded Funds (ETFs) aimed at delivering capital-efficient exposure to gold and U.S. small-cap equities while generating consistent income. The newly launched funds are the Simplify Gold Strategy PLUS Income...
Continue Reading
California's Bold Move Against Exxon Mobil The state of California has initiated a major lawsuit against Exxon Mobil, one of the world's leading oil companies, accusing it of being complicit in the global plastic waste crisis. This legal action was announced by Attorney General Rob Bonta during an event focused on the necessity of climate action. Details of the Lawsuit...
Continue Reading